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Abstract The specificity of the inositol 1,3,4,5-tetrak- 
isphosphate binding protein purified from porcine platelets [Cul- 
len et al. (1995) Biochem. J. 305, 139-143] was examined using 
all the isomers of myo-inositol tetrakisphosphate. From the rela- 
tive potencies of these compounds it appears that phosphorylation 
of the 1, 3 and 5 positions is essential for high affinity binding, 
that there is some tolerance of phosphorylation of the 6-hydroxyl, 
but none of a phosphate in the 2-position, and that phosphoryla- 
tion of the 4-hydroxyl has very little influence. The binding of 
Ins(1,3,4,5)P4 was not appreciably altered by physiological Mg 2÷ 
concentrations, and the pH dependence of binding under physio- 
logical conditions showed a decline from pH 5.5 to pH 9.0. 
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1. Introduction 
The issue of whether or not Ins(1,3,4,5)P4 is a second messen- 
ger, and if so what its function(s) may be, is currently still 
controversial [1,2]. One route to resolving the issue is to identify 
the molecular nature of putative Ins(1,3,4,5)P4 receptors [3], 
and to that end we have recently purified to homogeneity from 
porcine platelets an Ins( 1,3,4, 5)P4-binding protein which shows 
a high affinity and specificity for Ins(1,3,4,5)P4 [ ]. In our orig- 
inal study of the specificity of this protein, we investigated the 
efficacy of a number of other inositol phosphates, including 
three InsPa's (the 1,3,4,5; 3,4,5,6; and 1,3,5,6 (=L-1,3,4,5)) iso- 
mers, but this gives only an incomplete picture of the specificity 
of this protein. As yet we have only a very vague picture of the 
requirements of this protein with respect to which hydroxyls on 
the inositol ring must be phosphorylated for optimal binding 
(compare with our much more comprehensive knowledge of the 
Ins(1,4,5)P 3 receptor). Two of us (S-K.C. and Y-T.C.) have 
recently synthesised all the tetrakisphosphate isomers of myo- 
inositol [5]. The twelve asymmetric isomers are made as six 
racemic pairs and so cannot be tested individually, but in the 
present context (displacement of [32p]Ins(1,3,4,5)P4 from the 
protein) this does not matter, because ach pair will be domi- 
nated by the most potent enantiomer; moreover, as discussed 
below, other data with selected enantiomerically pure com- 
pounds resolves any ambiguity. Thus using these samples 
*Corresponding author. Fax: (44)(223) 833 511. 
Abbreviations: All inositol phosphate isomers are given in D-numbering 
unless otherwise stated. 
enables us to get an essentially complete picture of the isomeric 
specificity of the binding site on the pure protein. 
We also here report a few other properties of this protein. 
In particular, the use of a pure protein, now devoid of any 
Ins(1,3,4,5)P4 phosphatase activity, enables us for the first time 
to study Ins(1,3,4,5)P4 binding under near physiological condi- 
tions, with Mg 2÷ present. 
2. Materials and methods 
The Ins(l,3,4,5)P4 binding protein and radioligand (carrier-free 
[5-32P]Ins(1,3,4,5)P4) were prepared exactly as in [4] and binding assays 
were exactly as in that paper. 
The nine myo-inositol tetrakisphosphates (six racemic pairs and three 
meso-isomers) were synthesised as in Chung and Chang [5]. In brief, 
inositol 1,4 bisbenzoate was randomised by base-catalyst i omerisation, 
and the nine resulting inositol bisbenzoate isomers were purified by 
hplc, and identified by ~H and ~3C NMR including H-H COSY. Each 
of these was then phosphorylated by phosphitylation followed by oxi- 
dation, and de-protected bysuccessive treatments with trimethylsilyl 
bromide and KOH. 
3. Results and discussion 
3.1. Binding specificity 
Our previous tudies [4] on the purified Ins(1,3,4,5)P4-bind- 
ing protein from porcine platelets yielded a K d of 6.3 + 0.4 nM 
for Ins(1,3,4,5)P4 and Kds of 85.0 + 4.1 nM, 800.0 + 20.2 nM, 
65.6 + 2.6 nM, > 10/IM, 793.3 + 55.6 nM, and 85.0 + 5.9 nM 
for Ins(1,3,4,5,6)Ps, InsP6, GroPIns(3,4,5)P3, Ins(1,4,5)P3, 
Ins(3,4,5,6)P 4 and L-Ins(1,3,4,5)P4 (=Ins(1,3,5,6)P4), respec- 
tively. 
As a first stage in investigating the efficacy of all the synthetic 
InsP4 isomers, we conducted a preliminary screen using a par- 
tially purified InsP4-binding protein fraction (yields of pure 
protein are sufficiently low that quantifying so many different 
compounds would require a major investment of material). We 
used the binding peak from the heparin Hi-Trap column [4] 
which, like crude solubilised platelet membranes, shows an 
apparent Kd of 56.5 + 1.5 nM for Ins(1,3,4,5)P4 and yields a 
curved Scatchard transformation which can be fitted to two 
sites (P = 0.03 compared with a one site fit) having Kas of 
26.2 + 19.6 nM and 653.6 + 440.0 nM (results not shown, com- 
pare with [4]). 
The K~s of the nine InsP4 preparations are given in Table 1, 
and three things are readily apparent from these data. Firstly, 
om Ins(1,3,4,5)P4 is half as potent as l>Ins(1,3,4,5)P4, consistent 
with L-Ins(1,3,4,5)Pa being weaker than the D-isomer [4]. Sec- 
ondly, any InsP 4 with a phosphate inthe 2-position is essentially 
inactive. As this is only a partially purified fraction with two 
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Fig. 1. Effect of pH on Ins(1,3,4,5)P4 binding to the purified porcine 
platelet Ins(1,3,4,5)Pa-binding protein. Assays were performed as de- 
scribed in section 2 with buffers based on 100 mM KCI, 20 mM NaC1, 
1 mM EDTA, 0.1% (w/v) BSA and either 10 mM MES, 10 mM HEPES 
and 25 mM Tris for pH's 5.5~.5, 7.0-7.5 and 8.0-9.0, respectively. 
Non-specific binding was determined in the presence of 10 gM 
Ins(1,3,4,5)P4. 
apparent affinities, we cannot give precise numbers for what the 
potency of these isomers might be on the pure, high-affinity 
protein. Since all these isomers are so weak in this assay we can 
conclude that neither binding site can tolerate a phosphate in 
the 2-position in an InsP4, and we have therefore not explored 
them further. 
The third observation that stems from Table 1 is that D/L 
Ins(1,4,5,6)P4 is the only other sample that shows any signifi- 
cant (i.e. less than two orders of magnitude weaker than 
Ins(1,3,4,5)P4) ability to displace Ins(1,3,4,5)P4. We therefore 
studied D/L Ins(1,4,5,6)P4 further using the purified protein for 
which we already have K~s of 6.3 + 0.4 nM and 793.3 + 55.6 
nM for Ins(1,3,4,5)P4 and Ins(3,4,5,6)P4 (=L-Ins(1,4,5,6)P4), re- 
spectively [4]. In this set of experiments Dm Ins(1,4,5,6)P4 
showed a Kd of 390.0 + 48.9 nM compared with 6.4 + 0.2 nM 
for Ins(1,3,4,5)P4, suggesting that o-Ins(1,4,5,6)P4 is probably 
slightly more potent than L-Ins(I,4,5,6)P4, but that both are 
more than 50-fold weaker on the pure protein than 
Ins(1,3,4,5)P4. 
We can therefore now begin to suggest some criteria which 
can be regarded as being required for high affinity binding to 
this protein. As mentioned above, a 2-phosphate cannot be 
tolerated (see also the low affinity of lnsP6 [4]). There is some 
tolerance for a 6-phosphate (Ins(1,3,4,5,6)P5 vs. Ins(1,3,4,5)P4), 
and a 1-phosphate considerably strengthens binding 
(Ins(3,4,5,6)P4 vs. Ins(1,3,4,5,6)P 5 [4], and see also Ins(3,4,5)P3 
vs. Ins(1,3,4,5)P4 in [6]); there is some steric hindrance caused 
by a glycerol moiety on this phosphate (GroPIns(3,4,5)P3 vs. 
Ins(1,3,4,5)P4 [4]). A 3-phosphate is essential (Ins(1,4,5)P3 vs. 
Ins(1,3,4,5)P4), although if a 6-phosphate is added to 
Ins(1,4,5)P3 (to give lns(1,4,5,6)P4), that can exert a small effect 
to increase affinity. A 5-phosphate is essential for binding 
(Ins(1,3,4,6)P4 vs. Ins(1,3,4,5,6)Ps, and see also the lack of bind- 
ing of lns(1,3,4)P 3 in [6] and in many other studies on what are 
presumably similar binding sites, summarised in [1]). Phospho- 
rylation in the 4-position makes very little difference 
(Ins(1,3,5,6)P4 (= L-Ins(1,3,4,5)P4) vs. Ins(1,3,4,5,6)P5 [4]). Thus 
we can suggest hat the binding site on this protein recognises 
primarily the 1, 3 and 5 phosphates, with no tolerance for a 
2-phosphate, some tolerance of a 6-phosphate, and with the 
4-phosphate having little influence. 
3.2. Effect of  Mg 2+ 
We have earlier emphasised how Ins(1,3,4,5)P4 binding sites 
on membranes can be used to assay the mass of Ins(1,3,4,5)P4 
in unfractionated tissue extracts under both artificial [7,8] and 
nearer physiological [9] conditions. The latter study [9] was 
inevitably compromised, asare all such studies, by the omission 
of Mg 2+ from and inclusion of EDTA in the binding assay 
-essential to avoid degradation of the ligand by Mg2+-depend - 
ent phosphatases. It is entirely possible that Mg z+ might alter 
significantly the affinity or specificity of Ins(1,3,4,5)P4 binding, 
and thus would alter our interpretation f these studies namely, 
that Ins(1,3,4,5)P 4 is the most likely natural igand for these 
binding sites. 
The use of a pure protein enabled us to check this, and so 
we measured the affinity of Ins(1,3,4,5)P4, Ins(1,3,4,5,6)Ps, 
InsP6 and Ins(1,4,5)P3 with 2 mM Mg 2+ present. There was a 
clear increase in non-specific binding (from about 10% to 30%) 
but specific binding was not altered (data not shown), and we 
could not detect any significant change in the apparent affinity 
of any of the inositol phosphates tested. 
3.3. Effect of pH 
We have shown before [9] that effects o fpH on Ins(1,3,4,5)P4 
binding sites vary somewhat between tissues, and are also 
changed by the presence of 50 mM inorganic phosphate (or, put 
the way that we described it [9], the effect of inorganic phos- 
phate is different at pH 5.5 vs. pH 7.0). We therefore xamined 
(in the absence of inorganic phosphate) the effect of pH on the 
purified putative Ins(1,3,4,5)P4 receptor, partly to document 
the behaviour of this particular non-neuronal protein, but also 
to compare with the behaviour of three neuronal Ins(1,3,4,5)Pa- 
specific binding proteins tudied by Theibert et al. [10] using an 
InsP 4 affinity probe. Fig. 1 shows that at a single Ins(1,3,4,5)P4 
concentration, specific binding decreased steadily from pH 5.5 
to pH 9.0. In this it most closely resembles the p84 of Theibert 
et al. [10] and is markedly different from the p182 and p174 (and 
also the InsP6-binding protein, which the pharmacology of our 
present protein rules out as being the same). So, if any of these 
three proteins is the neuronal homologue of our platelet pro- 
tein, on this criterion alone, the p84 is the most likely. 
Table 1 
Efficacy of synthetic InsP 4 isomers using a partially purified porcine 
platelet Ins(1,3,4,5)P4-binding protein 
Inosito! phosphate (DIL isomer) IC50 (ttM) 
Ins(1,2,4,5)P4 8.1 +_ 0.1 
Ins(1,2,4,6)P4 6.3 + 0.1 
Ins(1,2,3,5)P4 > 10 
Ins(1,3,4,6)P4 8.2 + 0.4 
Ins(2,4,5,6)P4 5.8 + 0.1 
Ins(1,3,4,5)P4 0.098 + 0.01 
Ins(1,2,5,6)P4 -> 10 
Ins(1,2,3,4)P4 7.7 + 0.1 
Ins(1,4,5,6)P4 1.7 + 0.2 
o-Ins(1,3,4,5)P4 0.056 _+ 0.001 
Assays were performed at pH 7.0 as described in section 2. 
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4. Conclusion 
Overall we can conclude that a more detailed study of the 
properties of the purified platelet Ins(l,3,4,5)P4-binding protein 
has emphasised its specificity under physiological conditions, 
and so has increased rather than decreased the strength of our 
interpretation [3,4,9] that this protein is a reasonable candidate 
to be a physiological receptor for Ins(1,3,4,5)P4. As discussed 
in [4], although the current data support Ins(l,3,4,5)P4 as the 
most likely ligand, we cannot yet rule out PtdIns(3,4,5)P3 as an 
alternative physiological target for this protein, and the high 
specificity shown here for what is the head-group of that lipid 
is consistent also with that possibility. Resolving these issues 
will clearly require further study. 
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